Home LiteratureArticle Details
PMID: 20382238 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.

NeuroImage ·Vol. 52 ·No. 1 ·2010-08-01 ·Pages 109-18

Wolz R, Heckemann RA, Aljabar P, Hajnal JV, Hammers A, Lötjönen J, Rueckert D, Alzheimer's Disease Neuroimaging Initiative

Abstract

We propose a new method of measuring atrophy of brain structures by simultaneously segmenting longitudinal magnetic resonance (MR) images. In this approach a 4D graph is used to represent the longitudinal data: edges are weighted based on spatial and intensity priors and connect spatially and temporally neighboring voxels represented by vertices in the graph. Solving the min-cut/max-flow problem on this graph yields the segmentation for all timepoints in a single step. By segmenting all timepoints simultaneously, a consistent and atrophy-sensitive segmentation is obtained. The application to hippocampal atrophy measurement in 568 image pairs (Baseline and Month 12 follow-up) as well as 362 image triplets (Baseline, Month 12, and Month 24) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) confirms previous findings for atrophy in Alzheimer's disease (AD) and healthy aging. Highly significant correlations between hippocampal atrophy and clinical variables (Mini Mental State Examination, MMSE and Clinical Dementia Rating, CDR) were found and atrophy rates differ significantly according to subjects' ApoE genotype. Based on one year atrophy rates, a correct classification rate of 82% between AD and control subjects is achieved. Subjects that converted from Mild Cognitive Impairment (MCI) to AD after the period for which atrophy was measured (i.e., after the first 12 months) and subjects for whom conversion is yet to be identified were discriminated with a rate of 64%, a promising result with a view to clinical application. Power analysis shows that 67 and 206 subjects are needed for the AD and MCI groups respectively to detect a 25% change in volume loss with 80% power and 5% significance.

MeSH Terms
Aged Aging/pathology Algorithms Alzheimer Disease/diagnosis,genetics,pathology Apolipoproteins E/genetics Atlases as Topic Atrophy Automation Cognition Disorders/diagnosis,genetics,pathology Diagnosis, Differential Female Follow-Up Studies Hippocampus/pathology Humans Image Processing, Computer-Assisted/methods Longitudinal Studies Magnetic Resonance Imaging/methods Male Organ Size Reproducibility of Results Sensitivity and Specificity
Chemicals
Apolipoproteins E
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Wolz Robin
Department of Computing, Imperial College London, London, UK. [email protected]
Heckemann Rolf A
Aljabar Paul
Hajnal Joseph V
Hammers Alexander
Lötjönen Jyrki
Rueckert Daniel
Alzheimer's Disease Neuroimaging Initiative
Article Info
Journal
NeuroImage
Abbr.
Neuroimage
ISSN
1095-9572
Published
2010-08-01
Epub
2010-00-09
Pages
109-18
Language
English
Region
United States
NLM ID
9215515
Subset
IM
Grants
Medical Research Council · G108/585 · United Kingdom
Medical Research Council · MC_U120061309 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]